Home -> Law Blog Directory -> Patent Law Blogs -> Patently Obvious
(866) 635-2689 for Personal Injury or (866) 635-9402 for Criminal Defense
Find a Local Lawyer
Divorce (866) 635-6190
Personal Injury (866) 635-2689
Criminal Defense (866) 635-9402
Patent Law
: Patently ObviousReissue Cannot Merely Add New Dependent Claims (Without Cancelling the Broader Claims)
By Dennis Crouch, Esq.
Ex parte Tanaka (BPAI 2009) (Precedential)
The number of patents undergoing reissue is at an all-time high. [LINK] Often, patentees to prefer the reissue route over reexamination. In a reissue, for instance, an applicant may file RCEs and divisional applications. Those common elements of patent prosecution are prohibited during reexaminations. Likewise, claims can be broadened in a reissue, but not during reexamination. Finally, the time-pressure of reissue prosecution on the patentee is small comparable to that of reexamination.
Under 35 U.S.C. § 251, the reissue process is to correct an ?error? in a patent that would tend to make the patent ?wholly or partly inoperative or invalid.? The statute lists specific types of errors, including ?a defective specification or drawing, or by reason of the patentee claiming more or less than he had a right to claim in the patent.?
In this case, the patent applicant (Seiko) started a reissue process claiming that its mistake was in failing to include an additional narrower dependent claim to ?hedge against possible invalidity of the original claims.? The patentee did not cancel the broader claims because they were still potentially valid.
Issuing a precedential decision, the BPAI has interpreted Section 251 to bar reissue in this case.
[T]he Examiner found that because the reissue application contains all of the original patent claims and adds by reissue application only a single dependent claim 16, the reissue declaration cannot satisfy the error required under 35 U.S.C. § 251 because it cannot properly allege that the patent is wholly or partly inoperative or invalid by reason of the patentee claiming more or less than he had a right to claim in the patent.
We affirm.
This interpretation of Section 251 falls in-line with MPEP § 1402 and with the dicta of Hewlett-Packard Co. v. Bausch & Lomb, Inc., 882 F.2d 1556, 1565 (Fed. Cir. 1989).
Notes: Interestingly, Tanaka originally filed the reissue application and submitted a preliminary amendment that would broaden independent claim 1. (App No 10/201,948). After receiving a final rejection for the broadened claim, Tanaka changed its tactics; reinstated the original claim 1 and added a narrowed claim 16 that includes limitations not found in any other claim. At that time, Tanaka also submitted a substitute reissue declaration
Full post as published by Patently Obvious on January 20, 2010 (boomark / email).
Paxil Lawsuit
Paxil Claims, Lawsuits, and Injuries
False Claims
Attorney Robert Arledge ordered to pay $5.8 million after making false Fen Phen settlement claims.
LINA - Cigna Life Insurance Company of North America Disability Claims
LINA Insurance alleging violations of disability insurance claims.
Bayer to Pay $3.3 Million To Settle One A Day Vitamin Claims
Bayer to Pay $3.3 Million To Settle One A Day Vitamin Claims
Archdiocese of Denver
Settles 5.5 million in claims
BP
Settles More Claims From Texas Refinery Explosion
Warranty Parts Claims
Delphi Corp. must pay GM $200 million.

Narrowed Reissue Claim Invalid for Covering Embodiment Not Infringing Original Claim
BPAI: Reissue Not Available When Narrowing Contains All Original Patent Claims
Patent Office to Reissue Narrowed Version of NeoMedia Patent
Dependent claim can be construed to be broader than independent claim based on prosecution history
A First Glance at the Proposed New BPAI Rules
THINGS THAT DONT SUCK: Ive always admired those Bose noise-cancelling headphones, but they seemed









